The term ocular hypertension typically refers to any situation in which the pressure inside of the eye is higher than normal. Ocular hypertension is not considered a disease by itself, but it can lead ...

Iyuzeh is a preservative-free prostaglandin F2α analogue. The Food and Drug Administration (FDA) has approved Iyuzeh ™ (latanoprost ophthalmic solution) 0.005% for the reduction of elevated ...

Patients with type 1 diabetes have over four times the risk for glaucoma and ocular hypertension if they also have diabetic ...

Intraocular pressure, or eye pressure, is pressure from fluid inside the eye. Measuring intraocular pressure is important as high intraocular pressure can increase the risk of glaucoma. The eye ...

iDose TR is expected to be available in the first quarter of 2024. The Food and Drug Administration (FDA) has approved iDose ® TR (travoprost intracameral implant) for the reduction of intraocular ...

Glaucoma and hypertension were both linked with worsened cognitive performance, according to a poster presentation at the ...

Only about a quarter of patients with ocular hypertension lose peripheral vision, so clinicians should not recommend treatment to everyone with this condition, a long-term study suggests. The 20-year ...